Hundreds of ADHD patients are losing access to NHS prescriptions after a crackdown on shared care agreements. Many turned to private assessments due to lengthy NHS waiting times, only to find their medication suddenly unavailable. The move has left patients scrambling for alternatives. NHS trusts are terminating existing agreements, citing concerns over oversight and prescribing protocols.

Patients who relied on these arrangements now face renewed delays in accessing treatment. Private assessments became a lifeline for many during NHS backlogs that stretched over years. Clinics filled the gap, offering faster diagnoses and treatment plans.

However, NHS officials argue that proper oversight mechanisms weren't always in place. Patient advocates warn the decision could push more people toward unregulated online providers. The British ADHD Partnerships group called the move "reckless" during ongoing workforce shortages.

Healthcare professionals say sustainable solutions require investment in both NHS capacity and clearer regulatory frameworks for private sector collaboration.